Join our panel of experts as they explore the future landscape of clinical trials in 2030 and the key preparations needed today. This session will delve into emerging trends, technological advancements, and regulatory changes poised to reshape clinical research. Gain insights into the strategic planning and innovations required to stay ahead, ensuring your organization is ready to navigate and thrive in the evolving clinical trial environment.
Speakers:
Andy Corts, Chief Technology Officer, OneOncology, LLC
Carlos Orantes, CEO, Alcanza Clinical Research
Catherine Gregor, MBA, CCRP, CCRC, CCTO, Florence
Noelle Gaskill, MBA, ACRP-CP, VP, GM of Tempus Network, Tempus AI
Lauren Sutton, Head of Product, Clinical Trial Recruitment & Site CTMS, Verily
